SU1732815A3 - Способ получени гипотриглицеридально-активных полисахаридов - Google Patents

Способ получени гипотриглицеридально-активных полисахаридов Download PDF

Info

Publication number
SU1732815A3
SU1732815A3 SU843770904A SU3770904A SU1732815A3 SU 1732815 A3 SU1732815 A3 SU 1732815A3 SU 843770904 A SU843770904 A SU 843770904A SU 3770904 A SU3770904 A SU 3770904A SU 1732815 A3 SU1732815 A3 SU 1732815A3
Authority
SU
USSR - Soviet Union
Prior art keywords
perm
polysaccharide
psst
diet
fraction
Prior art date
Application number
SU843770904A
Other languages
English (en)
Russian (ru)
Inventor
Каваи Ясуо
Язава Казунага
Original Assignee
Кабусики Кайся Эдванс Каихацу Кенкюдзе (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кабусики Кайся Эдванс Каихацу Кенкюдзе (Фирма) filed Critical Кабусики Кайся Эдванс Каихацу Кенкюдзе (Фирма)
Application granted granted Critical
Publication of SU1732815A3 publication Critical patent/SU1732815A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SU843770904A 1983-07-27 1984-07-26 Способ получени гипотриглицеридально-активных полисахаридов SU1732815A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58135982A JPS6028401A (ja) 1983-07-27 1983-07-27 トリグリセリド低下活性多糖類

Publications (1)

Publication Number Publication Date
SU1732815A3 true SU1732815A3 (ru) 1992-05-07

Family

ID=15164420

Family Applications (1)

Application Number Title Priority Date Filing Date
SU843770904A SU1732815A3 (ru) 1983-07-27 1984-07-26 Способ получени гипотриглицеридально-активных полисахаридов

Country Status (12)

Country Link
US (1) US4687764A (enExample)
EP (1) EP0132981B1 (enExample)
JP (1) JPS6028401A (enExample)
AU (1) AU563995B2 (enExample)
CA (1) CA1239364A (enExample)
DD (1) DD222895A5 (enExample)
DE (1) DE3480217D1 (enExample)
ES (1) ES534629A0 (enExample)
HU (1) HU191697B (enExample)
MX (1) MX7693E (enExample)
PL (1) PL147734B1 (enExample)
SU (1) SU1732815A3 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5927833A (ja) * 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤
JPS59122428A (ja) * 1982-12-28 1984-07-14 Advance Res & Dev Co Ltd コレステロ−ル低下活性蛋白質
JPS61151128A (ja) * 1984-12-24 1986-07-09 Advance Res & Dev Co Ltd コレステロ−ル低下活性ｒｎａ画分
JPS625991A (ja) * 1985-07-03 1987-01-12 Advance Res & Dev Co Ltd コレステロ−ル乃至トリグリセリド低下活性ｒｎａ画分
US5202431A (en) * 1985-07-08 1993-04-13 Fidia, S.P.A. Partial esters of hyaluronic acid
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
JP2009149523A (ja) * 2006-03-01 2009-07-09 Ucc Ueshima Coffee Co Ltd 免疫賦活剤とその製造方法
CN103012615B (zh) * 2013-01-08 2015-02-25 广东海洋大学 一种高效提取乌贼墨酸性多糖的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52117492A (en) * 1975-12-11 1977-10-01 Hayashibara Biochem Lab Inc Preparation of water-insoluble glucan
US4251519A (en) * 1979-07-30 1981-02-17 Anheuser-Busch, Incorporated Process for the prevention and reduction of elevated blood cholesterol and triglycerides levels
JPS5943929B2 (ja) * 1979-08-13 1984-10-25 サッポロビール株式会社 多糖体ｒｂｓ物質，その製法およびそれを有効成分とする抗腫瘍性剤
JPS601877B2 (ja) * 1981-01-14 1985-01-17 明治乳業株式会社 高分子多糖類物質ｍｐｓ−８０及びその製造法
DE3305047A1 (de) * 1982-02-19 1983-09-22 Terumo Kabushiki Kaisha trading as Terumo Corp., Tokyo Polysaccharide, ihre herstellung und diese enthaltende therapeutische zusammensetzungen
JPS5927833A (ja) * 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. Патент СССР № 929015. кл. С 12 Р 19/04. 1982. *

Also Published As

Publication number Publication date
CA1239364A (en) 1988-07-19
MX7693E (es) 1990-08-24
DE3480217D1 (en) 1989-11-23
US4687764A (en) 1987-08-18
PL248970A1 (en) 1985-04-09
HUT34773A (en) 1985-04-28
PL147734B1 (en) 1989-07-31
ES8505722A1 (es) 1985-06-01
EP0132981B1 (en) 1989-10-18
EP0132981A2 (en) 1985-02-13
EP0132981A3 (en) 1986-01-29
DD222895A5 (de) 1985-05-29
JPH0365362B2 (enExample) 1991-10-11
AU563995B2 (en) 1987-07-30
JPS6028401A (ja) 1985-02-13
HU191697B (en) 1987-03-30
AU3048884A (en) 1985-01-31
ES534629A0 (es) 1985-06-01

Similar Documents

Publication Publication Date Title
EP0101209B1 (en) Hypocholesterolemically and/or hypotriglyceridemically active products
EP0455263A2 (en) Non-pyrogenic and non-irritating composition comprising sodium hyaluronate
JPS6216638B2 (enExample)
US4010258A (en) Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4812441A (en) Hypocholesterolemically active protein derived from streptococcus
IE47885B1 (en) Microbial fractions
US4687764A (en) Hypotriglyceridemically active polysaccharides
US3875007A (en) Lipid metabolism improving and anti-atheromatic agent
GB1567106A (en) Microbial fractions
EP0070656B1 (en) Immobilized superoxide dismutase, its production and pharmaceutical composition
CA1276897C (en) Hypocholesterolemically active rna fractions
PL91664B1 (enExample)
EP0196858A2 (en) Liver function-improving agent and blood pressure-lowering agent
EP0207700B1 (en) Hypocholesterolemically and/or hypotriclyceridemically active rna fractions
SU1756349A1 (ru) Штамм бактерий СоRYNевастеRIUм SереDоNIсUм - продуцент полисахарида, индуцирующего образование интерферона
CA1122526A (fr) Substance biologiquement active, sa preparation et les medicaments qui la contiennent
US3959467A (en) Lipid metabolism improving and anti-atheromatic agent
RU2231364C2 (ru) Способ получения капсульного вещества возбудителя мелиоидоза
SU1750690A1 (ru) Способ получени конъюгированного энтеротоксина ЕSснеRIснIа coLI
CA2123587A1 (fr) Produit bactericide, composition pharmaceutique le contenant et additif alimentaire
JPS63273471A (ja) Ａｔ−２５菌
EP0091745A1 (en) Preparation of an antibiotic selectively effective against staphylococcus infections
JPH01168291A (ja) コレステロールの吸着物質の製造方法
JPS5922517B2 (ja) 抗腫瘍性多糖類ｃ↓−４５の製造法
JPS6148920B2 (enExample)